AOD-9604

Where this compound appears in the literature

A modified C-terminal fragment of human growth hormone carrying an additional N-terminal tyrosine residue. Used in adipocyte research as a tool for studying lipolytic signalling independent of the full hGH molecule.

The areas below describe the experimental contexts in which AOD-9604 is cited. They are provided to help you assess whether the material suits your assay. They are not claims of effect, and nothing here should be read as suggesting any use in humans or animals.

• In-vitro adipocyte lipolysis assays
• Beta-3 adrenergic pathway research
• hGH structure-function fragment studies

Genexis Health does not provide research protocols, dosing guidance, administration instructions or interpretation of results. Experimental design is the responsibility of the purchasing laboratory and its ethics or safety committee.

Storage

Store lyophilised powder at -20 °C. Protect from oxidising conditions.

Solubility

Soluble in sterile water.

Laboratory handling

Allow the sealed vial to equilibrate to room temperature before opening to avoid condensation onto the lyophilised material. Prepare stock solutions using appropriate aseptic technique in a suitable containment environment, and label all derived solutions with the compound, concentration, date and the research-use restriction.

Handle as you would any uncharacterised research chemical: laboratory coat, gloves and eye protection, no eating or drinking in the work area, and no handling outside a controlled laboratory environment.

Disposal

Dispose of unused material, solutions and contaminated consumables through your institution's chemical waste stream in accordance with local regulations. Do not dispose of research materials in general waste or to drain.

Certificate of Analysis

Each lot of AOD-9604 is released with a Certificate of Analysis recording the lot number, HPLC purity chromatogram, mass spectrometry identity confirmation, appearance, and the date of analysis. The CoA for the current lot is available on request before purchase — email research@genexishealth.uk quoting the product name.

Safety data

A Safety Data Sheet is available for every catalog item. Research peptides are generally supplied as lyophilised solids with limited published toxicological data; treat any compound without a full hazard profile as potentially harmful and assess it under your own institutional risk assessment process.

Requesting documentation

Email research@genexishealth.uk with the product name and, where you already hold stock, the lot number printed on the vial. We retain analytical records for five years from the date of release.

Conditions of supply

AOD-9604 is sold subject to our Terms & Conditions and Research Use Only Policy. By placing an order you represent and warrant that:

• You are at least 21 years of age.
• You are acquiring the material for in-vitro laboratory research, or on behalf of an organisation that does so.
• You will not administer the material to a human or an animal, and will not transfer it to any person you believe intends to do so.
• You will comply with every law, licence, permit and institutional approval that applies to the material where you are located.
• You will store, handle and dispose of the material safely and lawfully once it leaves our custody.

Our right of refusal

We may refuse, cancel or refund any order at our discretion, including where a stated research purpose is missing or implausible, where an enquiry indicates intended human use, or where supply would breach any applicable restriction. See Compliance & Prohibited Use.

No warranty of fitness

Material is supplied to the specification on its Certificate of Analysis. Beyond that specification we give no warranty, express or implied, of fitness for any particular purpose. Determining suitability for your experiment is your responsibility.